Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Atherosclerosis
|
May 23, 2022
Recent advances in demystifying the metabolism of lipoprotein(a)
Kévin Chemello, Dick C Chan, Gilles Lambert, et al.
Journal of Lipid Research
|
August 16, 2023
PCSK9 and the nervous system: a no-brainer?
Ali K Jaafar, Romuald Techer, Kévin Chemello, et al.
Current Atherosclerosis Reports
|
March 31, 2022
Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms
Kévin Chemello, Dirk J Blom, A David Marais, et al.
Journal of Lipid Research
|
March 6, 2021
Lipoprotein metabolism in familial hypercholesterolemia
Kévin Chemello, Javier García-Nafría, Antonio Gallo, et al.
Journal of the American Heart Association
|
April 16, 2025
Apolipoprotein E Plasma Concentrations Are Predictive of Recurrent Strokes: Insights From the SPARCL Trial
Kévin Chemello, Alexis F Guedon, Romuald Techer, et al.
JACC. Advances
|
June 28, 2024
Lipoprotein(a): A Residual Cardiovascular Risk Factor in Statin-Treated Stroke Survivors: Insights From the SPARCL Trial
Kévin Chemello, Antonio Gallo, Alexis F Guedon, et al.
JCI Insight
|
May 8, 2025
PCSK9 deficiency promotes the development of peripheral neuropathy
Ali K Jaafar, Aurélie Paulo-Ramos, Guillaume Rastoldo, et al.
Cardiovascular Research
|
July 27, 2021
The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors
Valentin Blanchard, Kévin Chemello, Tim Hollstein, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 30, 2017
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab
Aurélie Thedrez, Dirk J Blom, Stéphane Ramin-Mangata, et al.
International Journal of Molecular Sciences
|
March 11, 2023
Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study
Floran Begue, Kévin Chemello, Bryan Veeren, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Atherosclerosis
|
May 23, 2022
Recent advances in demystifying the metabolism of lipoprotein(a)
Kévin Chemello, Dick C Chan, Gilles Lambert, et al.
Journal of Lipid Research
|
August 16, 2023
PCSK9 and the nervous system: a no-brainer?
Ali K Jaafar, Romuald Techer, Kévin Chemello, et al.
Current Atherosclerosis Reports
|
March 31, 2022
Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms
Kévin Chemello, Dirk J Blom, A David Marais, et al.
Journal of Lipid Research
|
March 6, 2021
Lipoprotein metabolism in familial hypercholesterolemia
Kévin Chemello, Javier García-Nafría, Antonio Gallo, et al.
Journal of the American Heart Association
|
April 16, 2025
Apolipoprotein E Plasma Concentrations Are Predictive of Recurrent Strokes: Insights From the SPARCL Trial
Kévin Chemello, Alexis F Guedon, Romuald Techer, et al.
JACC. Advances
|
June 28, 2024
Lipoprotein(a): A Residual Cardiovascular Risk Factor in Statin-Treated Stroke Survivors: Insights From the SPARCL Trial
Kévin Chemello, Antonio Gallo, Alexis F Guedon, et al.
JCI Insight
|
May 8, 2025
PCSK9 deficiency promotes the development of peripheral neuropathy
Ali K Jaafar, Aurélie Paulo-Ramos, Guillaume Rastoldo, et al.
Cardiovascular Research
|
July 27, 2021
The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors
Valentin Blanchard, Kévin Chemello, Tim Hollstein, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 30, 2017
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab
Aurélie Thedrez, Dirk J Blom, Stéphane Ramin-Mangata, et al.
International Journal of Molecular Sciences
|
March 11, 2023
Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study
Floran Begue, Kévin Chemello, Bryan Veeren, et al.
Page
of 2